Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylaxis in developed and in emerging countries.

J Tusell1, R Pérez-Bianco

  • 1Hospital Vall d'Hebron, Barcelona, Spain, Academia Nacional de Medicina, Buenos Aires, Argentina. jtusell.hmi@cs.vhebron.es

Haemophilia : the Official Journal of the World Federation of Hemophilia
|May 16, 2002
PubMed
Summary

Advances in factor concentrates enable preventative medicine for congenital bleeding disorders. This approach aims to maintain factor levels above 1-2%, transforming severe hemophilia into a moderate condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical synovectomy vs. radioactive synovectomy for the treatment of chronic haemophilic synovitis: a prospective short-term study.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Musculoskeletal evaluation in severe haemophilia A patients from Latin America.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

European study on orthopaedic status of haemophilia patients with inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2007
Same author

Transplacental transfer of propofol in pregnant ewes.

Veterinary journal (London, England : 1997)·2003
Same author

Haemophilia prophylactic treatment in Spain.

Haemophilia : the official journal of the World Federation of Hemophilia·2002
Same author

BS-SEM evaluation of the tissular interactions between cortical bone and calcium-phosphate covered titanium implants.

Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie·2002

Area of Science:

  • Hematology
  • Internal Medicine
  • Preventative Medicine

Background:

  • Recent advancements in plasma-derived and recombinant factor concentrates have significantly improved safety and efficacy.
  • Traditional treatment for congenital bleeding disorders focused on episodic or on-demand management of bleeding events.

Purpose of the Study:

  • To explore the application of preventative medicine principles in managing congenital bleeding disorders.
  • To assess the feasibility of maintaining minimum factor levels for improved patient outcomes.

Main Methods:

  • Development of new treatment programs utilizing advanced factor concentrates.
  • Focus on achieving and sustaining a minimum factor level of 1-2% in patients.

Main Results:

Related Experiment Videos

  • Established treatment programs that move beyond purely curative or consequence-focused interventions.
  • Demonstrated the potential to convert severe hemophilia into a moderate form of the disorder.

Conclusions:

  • Preventative medicine strategies are now viable for congenital bleeding disorders due to improved factor concentrate therapies.
  • Maintaining consistent, low-level factor replacement can significantly alter the disease's severity and impact on patients.